Yi-qun S. Chang

Guangzhou 510632, PR China
Puerto Rico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Hexadentate 3-hydroxypyridin-4(1H)-ones as dual biofilm inhibition and dispersion agents against Pseudomonas aeruginosa potentiate ciprofloxacin activity.

Hexadentate 3-hydroxypyridin-4(1H)-ones as dual biofilm inhibition and dispersion agents against Pseudomonas aeruginosa potentiate ciprofloxacin activity.

Journal: Bioorganic & medicinal chemistry letters

Published: May 18, 2026

Discovery of Catechol-Benzothiazole Conjugates as Antibacterial Synergists against Pseudomonas aeruginosa by Inhibiting Biofilm Formation.

Discovery of Catechol-Benzothiazole Conjugates as Antibacterial Synergists against Pseudomonas aeruginosa by Inhibiting Biofilm Formation.

Journal: Journal of medicinal chemistry

Published: May 04, 2026

Corrigendum to 'Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection' [Eur J Med Chem. 263 (2024) 115972].

Corrigendum to 'Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection' [Eur J Med Chem. 263 (2024) 115972].

Journal: European journal of medicinal chemistry

Published: December 12, 2025

Prevention of medication-related osteonecrosis of the jaw: institutional insights from a retrospective study.

Prevention of medication-related osteonecrosis of the jaw: institutional insights from a retrospective study.

Journal: Australian dental journal

Published: November 18, 2024

Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection.

Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection.

Journal: European journal of medicinal chemistry

Published: October 24, 2023

Discovery of N-(phenylsulfonyl)thiazole-2-carboxamides as potent α-glucosidase inhibitors.

Discovery of N-(phenylsulfonyl)thiazole-2-carboxamides as potent α-glucosidase inhibitors.

Journal: Drug development research

Published: August 06, 2023

New Pqs Quorum Sensing System Inhibitor as an Antibacterial Synergist against Multidrug-Resistant Pseudomonas aeruginosa.

New Pqs Quorum Sensing System Inhibitor as an Antibacterial Synergist against Multidrug-Resistant Pseudomonas aeruginosa.

Journal: Journal of medicinal chemistry

Published: December 24, 2021

Hybrids of arenobufagin and benzoisoselenazol reducing the cardiotoxicity of arenobufagin.

Hybrids of arenobufagin and benzoisoselenazol reducing the cardiotoxicity of arenobufagin.

Journal: Bioorganic & medicinal chemistry letters

Published: May 08, 2018

4-arylamidobenzyl substituted 5-bromomethylene-2(5H)-furanones for chronic bacterial infection.

4-arylamidobenzyl substituted 5-bromomethylene-2(5H)-furanones for chronic bacterial infection.

Journal: European journal of medicinal chemistry

Published: September 10, 2017

Strigolactones: a plant phytohormone as novel anti-inflammatory agents.

Strigolactones: a plant phytohormone as novel anti-inflammatory agents.

Journal: MedChemComm

Published: September 08, 2017

Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors.

Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors.

Journal: European journal of medicinal chemistry

Published: September 25, 2016

Prediction and evaluation of the lipase inhibitory activities of tea polyphenols with 3D-QSAR models.

Prediction and evaluation of the lipase inhibitory activities of tea polyphenols with 3D-QSAR models.

Journal: Scientific reports

Published: April 16, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026